With the Ministry of Health’s latest pledge to improve upon medical legislation, international businesses continue to pin high hopes on marketing authorisation regulations for medical devices and distribution rights in order to drive their plans forward.| Vietnam Investment Review - VIR
In today’s pharmaceutical landscape, complexity is the new normal. With decentralised clinical trials, personalised medicines and direct-to-patient therapies on the rise, pharma supply chains must... The post Why Small Parcels are a Big Test for Contract Pharma appeared first on .|
The oversubscribed seed funding will be used to improve the storage and transportation of life-saving medicines, the company said.| Silicon Republic
Examining generative AI in healthcare: innovations, consumer views, and pressing ethical considerations.| AI Accelerator Institute
Real-world insights from the front lines of clinical AI| AI Accelerator Institute
Obesity and type 2 diabetes are among the cardiometabolic diseases included in Novo Nordisk’s R&D pact with Replicate Bioscience, a deal that could pay out up to $550 million. Startup Replicate specializes in therapies and vaccines based on self-replicating RNA. The post Novo Nordisk Turns to Self-Replicating RNA Startup to Discover New Metabolic Medicines appeared first on MedCity News.| MedCity News
Susan Monarez has been fired from her role as CDC director less than a month after her confirmation, following reported clashes with HHS Secretary Robert F. Kennedy Jr. over vaccine policy. This news comes amid a period of turmoil at the CDC, including a recent deadly shooting at its headquarters. The post CDC Director Ousted After Less Than a Month on the Job appeared first on MedCity News.| MedCity News
[Sponsored] Using RWD to understand SDOH factors faced by patients with non-small cell lung cancer paves the way for improving health equity and more effective treatments for more people. The post The Role of RWD in Revolutionizing Clinical Trial Design appeared first on MedCity News.| MedCity News
Cemdisiran, a small interfering RNA drug that Regeneron Pharmaceuticals licensed from Alnylam Pharmaceuticals, met the goals of its pivotal test in generalized myasthenia gravis. The rare neuromuscular disease has several new therapies, but analysts see cemdisiran as having advantages over one particular class of drugs. The post Regeneron’s RNA Med for Muscle Disease Meets Trial Goals; FDA Filing Planned for Next Year appeared first on MedCity News.| MedCity News
LB Pharmaceuticals’ planned IPO will fund late-stage clinical development of LB-102, a once-daily pill designed to improve on the old Sanofi schizophrenia drug Solian. The IPO filing follow a corporate restructuring in May that cut the jobs of LB’s chief financial and scientific officers to streamline operations and extend its cash runway. The post With a New Take on an Old Schizophrenia Drug, LB Pharma Prepares IPO to Fund Phase 3 Test appeared first on MedCity News.| MedCity News
Valneva must immediately cease U.S. shipments and sales of Ixchiq, a vaccine for chikungunya virus. The FDA recently lifted a pause on dosing of Ixchiq, but the agency’s new safety alert is based on an assessment that found the vaccine appears to be causing chikungunya-like illness in recipients. The post FDA Suspends Valneva Vaccine’s License Following New Reports of Adverse Events appeared first on MedCity News.| MedCity News
As Europe’s implementation of ISO IDMP data standards progresses, EMA’s centralised Product Management Services (PMS) platform is emerging as the next priority for the life... The post The Next Phase in EU ISO IDMP Adoption Affecting Medtech and Connected Health: Product Management Services appeared first on .|
Prior to her time at Lightstone, Gaynor worked at a number of early-stage medical device start-ups, spending more than a decade in pharma.| Silicon Republic
Drug diversion is rampant in the United States, occurring in nearly every hospital and health system. We spoke with Tom Knight, the Founder and Chairman... The post The Fight to Stop Drug Diversion – How One Non-profit is Changing the System appeared first on .|
Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s room for many MASH drugs with the treatment landscape expected to shape up to include combinations of therapies bringing different approaches to this fatty liver disease.| MedCity News
The Parkinson’s disease market across 7MM is forecast to grow at a CAGR of 7.6% from $3.4 billion in 2023 to $7.0 billion in 2033, according to GlobalData.| GlobalData
The White House Office of Management and Budget blocked the National Institutes from issuing grant funding and contracts but then reversed course after uproar ensued.| Bruce Lee
America's pharmaceutical giants have been plotting to torpedo Australia's Pharmaceuticals Benefits Scheme, despite securing major concessions 20 years ago.| www.abc.net.au
Which Location Tracking Technology is Best for Pharmaceutical Manufacturing & Labs? In pharmaceutical manufacturing and laboratory environments, precision isn’t optional — it’s essential. The margin for error is incredibly slim. A single misplaced piece of equipment, the unplanned absence of a technician, or an error in timing can ruin an entire batch or compromise| Ubisense
The Cold Chain Crisis: How Pharma Companies Can Prevent Spoilage and Loss Pharmaceutical supply chains are under more scrutiny than ever before. Among the most fragile elements is the cold chain: a temperature-controlled logistics process critical to preserving the efficacy of vaccines, biologics, cell and gene therapies, and other temperature-sensitive drugs. As global demand| Ubisense
How AI and RTLS Are Transforming Pharma Manufacturing Compliance Pharmaceutical manufacturers operate in one of the most highly regulated industries, where compliance with FDA, EMA, GxP, and GMP standards is non-negotiable. The complexity of modern pharma production—especially with the rise of biologics, personalized medicine, and advanced therapies—requires unprecedented levels of traceability and automation. At| Ubisense
And more biotech news brought to you by The Readout.| STAT
See how the UK's £225m Isambard-AI supercomputer is set to revolutionize drug and vaccine development using cutting-edge AI technology.| AI Accelerator Institute
What if artificial intelligence could help us solve some of the most complex challenges in pediatric healthcare, especially when it comes to rare diseases?| AI Accelerator Institute
If approved, AP301 could potentially address two unmet needs in HP management: poor patient adherence and inadequate phosphorus control, says GlobalData.| GlobalData
CANNES – The promise of AI-powered creative versioning and real-time optimization in healthcare marketing faces a fundamental obstacle: regulatory review processes that haven�...| Beet.TV - The Root to the Media Revolution
CANNES – The fragmentation that has long plagued television advertising may finally be giving way to consolidation, creating new opportunities for precision targeting in healthc...| Beet.TV - The Root to the Media Revolution
Sarepta Therapeutics refused a FDA request to halt shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy| STAT
The new XFG SARS-CoV-2 variant is behind a COVID-19 surge in Southeast Asia and has been designated by the World Health Organization as a “variant under monitoring.”| Bruce Lee
Big Pharma prepare for next patent cliff as blockbuster drugs revenue losses loom, says GlobalData| GlobalData
The $100 Billion Secret: Why Leading Pharma Companies Outsource Their Commercial Data Teams| DataKitchen
After making gains in 2022, multinational corporations will prioritise strengthening local partnerships to support their ambition of transforming the treatment landscape – but they are also pleading for further legal clarity.| Vietnam Investment Review - VIR
AstraZeneca announced May 7th it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a “surplus of available updated vaccines” since the pandemic. A request to withdraw it from European markets had been filed since March The company also proceeded to withdraw the vaccine Vaxzevria’s marketing authorizations within Europe. It submitted a withdrawal […] The post Astrazeneca Withdraws The Covid-19 Vaccine From All Markets Because Of Declining Demand appeared first on He...| Healthcare Weekly
Amgen announced May 2nd financial results for the first quarter 2024, and its shares soared right after the announcement, which was followed closely by a FDA approval of a lung-cancer drug. “With many of our innovative products delivering strong growth and promising new medicines advancing through our pipeline, we are excited about delivering attractive long-term […] The post Amgen Shares Value Rose After Financial Results And New Drug Related Announcement appeared first on Healthcare Wee...| Healthcare Weekly
A new Alzheimer’s treatment could cost Medicare billions of dollars by next year — well over Wall Street or even the drug’s manufacturer projections — according to a document obtained by STAT. 5.5 million people in the U.S. suffer from Alzheimer’s disease Declining general health is natural as one grows older. However, struggling with Alzheimer’s […] The post A New Alzheimer’s Treatment Could Cost Medicare Billions of Dollars by 2025 appeared first on Healthcare Weekly.| Healthcare Weekly
AI can create models that predict a compound’s potential and run this model on millions of compounds to find the most promising options.| AI Accelerator Institute
Discover how generative AI is transforming drug discovery, medical imaging, and patient outcomes to accelerate advancements with AstraZeneca| AI Accelerator Institute
An Interview with Dr. Robert Seik, PharmD When big Pharma sold American out for Covid Profits and politics by denying treatment, independent pharmacists saved the day. Are big chain pharmacies a risk to national security? What else have our medical establishments been hiding? When big business stands in the way to good health, it’s time […] The post Independant Pharmacies Saved America appeared first on Broken Truth.| Broken Truth
Marketing Masterminds discusses how to find the top pharmaceutical sales recruiters for growing teams. Where to get the best big pharma RX sellers.| www.marketingmasterminds.org
Repare Therapeutics is cutting discovery and preclinical work to focus on its clinical-stage cancer drugs. The most advanced program is camonsertib, whose rights Repare recently regained from Roche after the pharma giant terminated an alliance started in 2022.| MedCity News
OMNY Health — a national data ecosystem that facilitates biotech and medical research — launched a data network consisting of EHR data from more than 645,000 GLP-1 users. The data network seeks to give OMNY’s life sciences and health system partners a vast source of GLP-1 data that is related to patient demographics and social determinants of health.| MedCity News
Data Quality Circles: The Key to Elevating Data and Analytics Team Performance| DataKitchen
Hello PhaMed Readers, We want to start this issue with a sincere apology. We know you've been eagerly waiting for issue 8 of our newsletter, and we deeply regret that it has arrived later than expected. Unexpected challenges disrupted our usual publishing schedule, and we are truly sorry. Your patience, understanding, and unwavering support [...] The post Consent document translation expense hinders inclusive clinical trial enrolment! appeared first on Ali Saad Arabic Translation Services.| Ali Saad Arabic Translation Services
🏥 Breaking Boundaries in Healthcare: 🌟 Discover the latest advancements revolutionizing the industry. From tackling antimicrobial resistance 💪 to AI-generated drugs 💊 and high-tech wound healing 🩹, this issue of PhaMed TransBrief brings you the most compelling stories. 📰 Explore the FDA's new tools for food traceability 🍔, game-changing acquisitions 💰, clinical trial breakthroughs 🎉, AI's [...] The post Your Mobile as a Thermometer and a Smoking Cessation Helper! ...| Ali Saad Arabic Translation Services
Welcome to the sixth issue of PhaMed TransBrief, your go-to source for the latest news and insights in the pharmaceutical industry. We hope you enjoy this issue of PhaMed TransBrief! (Read Time: 4 min.) PhaMed Top Stories New AMR certification launched for antibiotic manufacturers A new certification has been launched to promote responsible antibiotic [...] The post Revolutionizing Pharma: From AMR Certification to Green Energy Solutions and Market Battles appeared first on Ali Saad Arabic T...| Ali Saad Arabic Translation Services
Hello, PhaMed TransBrief's Friends. 👋 We curated some of the most exciting stuff in the #pharma industry within the last fourteen days. 💊💉 Invest only 4 minutes of your time to look at this brief. 👀🕑 PhaMed Top Stories Don't delay reforms to prepare for next pandemic, World Health Organization chief says [...] The post Don’t delay reforms to prepare for next pandemic appeared first on Ali Saad Arabic Translation Services.| Ali Saad Arabic Translation Services
Hello, PhaMed TransBrief subscribers and newcomers. Here's the fourth issue with great news, job opportunities, and large pharma collaborations. Invest just five minutes of your time and discover something great! 🕑 Check out this brief that's sure to catch your interest. 💡 Top PhaMed Stories WHO downgrades COVID pandemic, says it’s no longer emergency [...] The post Great Pharma News and Opportunities. Don’t miss out on something amazing. appeared first on Ali Saad Arabic Translatio...| Ali Saad Arabic Translation Services
Hello everyone, pharma professionals and lovers. Here's the third issue of your newsletter made with ❤ by Ali Saad Agency for Translation Services. You need 6-7 mins only to read this biweekly brief. Pharma Game Changers Merck to buy Prometheus Biosciences for about $11 billion Merck & Co has agreed to acquire Prometheus Biosciences, [...] The post 25 Migraine Meds Comparison appeared first on Ali Saad Arabic Translation Services.| Ali Saad Arabic Translation Services
Welcome to our newest subscribers. Pharma stakeholders and pharma lovers, this newsletter is growing with you. Here's the welcome issue. We save ten hours of your time to enjoy reading this brief in only 6-7 mins. PhaMed Top Stories Biden ends COVID national emergency after Congress acts President Joe Biden signed a [...] The post 5 Top Tips for Biopharma Candidates appeared first on Ali Saad Arabic Translation Services.| Ali Saad Arabic Translation Services
Short Story Let us reflect on this short story below. A large pharmaceutical company had just launched a new medical product to treat a rare disease. The medicine had undergone extensive clinical trials, and the company was confident in its efficacy. The company had decided to expand its operations in the Middle East and [...] The post How Arabic Translation Services Can Help the Pharma Industry appeared first on Ali Saad Arabic Translation Services.| Ali Saad Arabic Translation Services
We can’t wait for others to find a solution to high drug prices. It’s clear what should happen in a functioning drug pricing market federally and in California, but it is not happening today.| MedCity News
